Engimmune Therapeutics
Pre-clinicalEngimmune Therapeutics - Engineering the next-generation of soluble T cell receptor (TCR) therapies in oncology and immune-mediated disease.
Founded
2018
Focus
Cell & Gene Therapy
About
Engimmune Therapeutics - Engineering the next-generation of soluble T cell receptor (TCR) therapies in oncology and immune-mediated disease.
Funding History
1Total raised: $25M
Series A$25MVersant VenturesJun 15, 2023
Company Info
TypePrivate
Founded2018
LocationBasel, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile